← Browse by Condition
Medical Condition
head neck cancer
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 2
NCT07285564
Recruiting
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
Enrollment
10 pts
Location
France
Sponsor
Centre Henri Becquerel
NCT05838729 Phase 1, Phase 2
Recruiting
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
Enrollment
16 pts
Location
United States
Sponsor
Coordination Pharmaceuticals, ...
NCT07353723 Phase 2
Recruiting
Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer
Enrollment
10 pts
Location
China
Sponsor
Tang-Du Hospital
NCT07448727
Recruiting
Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT
Enrollment
25 pts
Location
Italy
Sponsor
University of Rome Tor Vergata